FDA Releases DTC Guidances; "Not The Last Word" On Ads, Commissioner McClellan Says
This article was originally published in The Pink Sheet Daily
Executive Summary
The agency pledges further review of its guidance on direct-to-consumer advertising. Broadcast ads for drugs and enforcement actions against repeat offenders could see more attention.
You may also be interested in...
FDA To Investigate Role Of Context Of Risk Information In DTC Print Ads
Agency will undertake two consumer studies to determine possible options for improving communication of risk information in ads.
FDA To Investigate Role Of Context Of Risk Information In DTC Print Ads
Agency will undertake two consumer studies to determine possible options for improving communication of risk information in ads.
WLF’s “DDMAC Watch” Objects To Vitrase Ad Division Letter
Including the full risk information in the “brief summary” portion of promotional materials is sufficient, Washington Legal Foundation says.